0001237899-13-000021.txt : 20130402 0001237899-13-000021.hdr.sgml : 20130402 20130402092353 ACCESSION NUMBER: 0001237899-13-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130401 FILED AS OF DATE: 20130402 DATE AS OF CHANGE: 20130402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L CENTRAL INDEX KEY: 0001225474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 13733511 MAIL ADDRESS: STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS STREET 2: 5323 HARRY HINES BLVD CITY: DALLAS STATE: TX ZIP: 75390 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-04-01 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001225474 GOLDSTEIN JOSEPH L 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2013-04-01 4 M 0 5000.0 24.41 A 5000 D Common Stock 2013-04-01 4 S 0 5000.0 180.0 D 0 D Non-Qualified Stock Option (right to buy) 24.41 2013-04-01 4 M 0 5000.0 D 2020-01-04 Common Stock 5000 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Joseph L. Goldstein 2013-04-01